Semi-Annual Statement Of Cash Flows

Chiome Bioscience Inc. - Filing #7720780

Concept As at
2018-06-30
2018-01-01 to
2018-06-30
As at
2017-12-31
2017-01-01 to
2017-06-30
As at
2017-06-30
As at
2016-12-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-602,714,000 JPY
-388,320,000 JPY
Depreciation
3,508,000 JPY
5,422,000 JPY
Decrease (increase) in trade receivables
8,666,000 JPY
-3,218,000 JPY
Decrease (increase) in inventories
-4,959,000 JPY
-3,863,000 JPY
Increase (decrease) in trade payables
11,996,000 JPY
1,762,000 JPY
Other, net
-56,528,000 JPY
-9,656,000 JPY
Subtotal
-689,562,000 JPY
-383,403,000 JPY
Interest paid
JPY
-148,000 JPY
Income taxes paid
-2,420,000 JPY
-2,420,000 JPY
Net cash provided by (used in) operating activities
-690,438,000 JPY
-385,889,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
JPY
-4,975,000 JPY
Purchase of investment securities
JPY
-150,000,000 JPY
Net cash provided by (used in) investing activities
JPY
-154,975,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-4,159,000 JPY
-29,169,000 JPY
Proceeds from issuance of shares
JPY
529,785,000 JPY
Net cash provided by (used in) financing activities
-4,159,000 JPY
500,616,000 JPY
Net increase (decrease) in cash and cash equivalents
-694,597,000 JPY
-40,248,000 JPY
Cash and cash equivalents
3,332,869,000 JPY
4,027,466,000 JPY
4,512,929,000 JPY
4,553,178,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.